Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Stockholders Equity of $12.70 billion for fiscal year 2025.
ZIMMER BIOMET HOLDINGS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $12.70B | +1.8% |
| 2024 | $12.47B | -0.1% |
| 2023 | $12.48B | +3.8% |
| 2022 | $12.02B | -5.1% |
| 2021 | $12.66B | +3.8% |
| 2020 | $12.19B | -1.6% |
| 2019 | $12.39B | +9.9% |
| 2018 | $11.27B | -4.0% |
| 2017 | $11.74B | +21.4% |
| 2016 | $9.67B | -2.2% |
| 2015 | $9.89B | +51.0% |
| 2014 | $6.55B | +4.0% |
| 2013 | $6.30B | +7.4% |
| 2012 | $5.86B | +6.4% |
| 2011 | $5.51B | -4.6% |
| 2010 | $5.77B | +2.4% |
| 2009 | $5.64B | -0.2% |
| 2008 | $5.65B | +3.6% |
| 2007 | $5.45B | +10.7% |
| 2006 | $4.92B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.76B | +3.1% | +1.8% |
| June 30, 2025 | $12.53B | -1.7% | +1.0% |
| March 31, 2025 | $12.40B | -1.6% | -0.6% |
| December 31, 2024 | $12.47B | -0.1% | +0.8% |
| September 30, 2024 | $12.37B | -1.1% | -2.9% |
| June 30, 2024 | $12.74B | +3.0% | +1.1% |
| March 31, 2024 | $12.60B | +3.7% | +0.9% |
| December 31, 2023 | $12.48B | +3.8% | -0.2% |
- ZIMMER BIOMET HOLDINGS, INC. showed an increase of +1.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, ZIMMER BIOMET HOLDINGS, INC.’s stockholders equity has grown by 157.9% (from $4.92 billion to $12.70 billion).
- The most recent figure is from ZIMMER BIOMET HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: